| 缩写名/全名 |
EUR REV MED PHARMACO
European Review for Medical and Pharmacological Sciences |
||||||||||||||||
| ISSN号 | 1128-3602 | ||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||
| 影响因子 | 2015:1.575, 2016:1.778, 2017:2.387, 2018:2.721, 2019:3.024, | ||||||||||||||||
| 出版国家 | ITALY | ||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||
| 年文章数 | 1345 | ||||||||||||||||
| 出版年份 | 1997 | ||||||||||||||||
| 是否OA | Yes | ||||||||||||||||
| 审稿周期(仅供参考) | 较快,2-4周 |
||||||||||||||||
| 录用比例 | 容易 | ||||||||||||||||
| 投稿链接 | http://www.europeanreview.org/page/1 | ||||||||||||||||
| 投稿官网 | http://www.europeanreview.org/ | ||||||||||||||||
| h-index | 48 | ||||||||||||||||
| CiteScore |
|
||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1128-3602%5BISSN%5D | ||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition. Author: Liao J1, Dong LP. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3829-3837. doi: 10.26355/eurrev_201905_17810. PubMed DOI |
| 2. | COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner. Author: Jiang GB1, Fang HY, Tao DY, Chen XP, Cao FL. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3838-3846. doi: 10.26355/eurrev_201905_17811. PubMed DOI |
| 3. | Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling. Author: Wei Y1, Ouyang GL, Yao WX, Zhu YJ, Li X, Huang LX, Yang XW, Jiang WJ. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3847-3856. doi: 10.26355/eurrev_201905_17812. PubMed DOI |
| 4. | KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway. Author: Liu FF1, Dong L, Yang X, Li DJ, Shen YY, Liu ZL. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3867-3875. doi: 10.26355/eurrev_201905_17814. PubMed DOI |
| 5. | MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma. Author: Sun YW1, Li XH, Wang H, Wu J. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3876-3884. doi: 10.26355/eurrev_201905_17815. PubMed DOI |
| 6. | MiR-122-3p regulates the osteogenic differentiation of mouse adipose-derived stem cells via Wnt/β catenin signaling pathway. Author: Hao W1, Liu HZ, Zhou LG, Sun YJ, Su H, Ni JQ, He T, Shi P, Wang X. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3892-3898. doi: 10.26355/eurrev_201905_17817. PubMed DOI |
| 7. | Inhibition of miR-17-5p promotes mesenchymal stem cells to repair spinal cord injury. Author: Yue XH1, Guo L, Wang ZY, Jia TH. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3899-3907. doi: 10.26355/eurrev_201905_17819. PubMed DOI |
| 8. | Correlation study on β2-adrenergic receptor gene polymorphisms and asthma susceptibility: evidence based on 57 case-control studies. Author: Yu X1, Wang LW, He Q, Khan K, Chen XY, Li J. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3908-3925. doi: 10.26355/eurrev_201905_17820. PubMed DOI |
| 9. | The expression of TRPM7 in serum of patients with sepsis, its influences on inflammatory factors and prognosis, and its diagnostic value. Author: Liu H1, Wang SY, Li XD, Yang S, Liu XY, Yang CW, Liu YF. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3926-3932. doi: 10.26355/eurrev_201905_17821. PubMed DOI |
| 10. | Effects of long non-coding RNA NEAT1 on sepsis-induced brain injury in mice via NF-κB. Author: Liu WQ1, Wang YJ, Zheng Y, Chen X. Journal: Eur Rev Med Pharmacol Sci. 2019 May;23(9):3933-3939. doi: 10.26355/eurrev_201905_17822. PubMed DOI |
|
|
